Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05952882Phase 3Not yet recruiting
A Phase 3 trial of liraglutide in polycystic ovary syndrome (PCOS), obesity, infertility, sponsored by My Duc Hospital. Planned start Nov 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05952882.